IL-9 was initially studied in allergic diseases, where it exerts a detrimental pro-inflammatory activity by promoting the expression of the Th2-related chemokines CCL17 and CCL22, known to be associated with allergic inflammation [53]. This evidence concerns the gene IL9 and allergic disease.